NHS C3 azidi, ≥95%, 5 mg, confezione in plastica.

(9bR)-2,6-diacetyl-1,7,9-trihydroxy-8,9b-dimethyldibenzo[b,d]furan-3(9bH)-one, 98.0%, 25g

5,6-Dimethyl-2-oxo-1,2-dihydropyridine-3-carbonitrile, 95.0%, 1g

Diphenyl(4-vinylphenyl)phosphane, 98+%, 1g

Dimethyl 5-methylpyridine-2,3-dicarboxylate, 97.0%, 500g

4,4,4-trifluoro-3,3-dimethylbutanoic acid, 95.0%, 250mg

2-Thioxo-2,3-dihydropyrido[3,4-d]pyrimidin-4(1H)-one, 95.0%, 100g

(4-Formyl-3,5-dimethoxyphenyl)boronic acid, 95.0%, 25g

1-(furan-2-yl)-3-hydroxy-4-methylpent-2-en-1-one, 98%, 500mg

Ethyl 2-(2-aminopyrimidin-4-yl)acetate, 95.0%, 1g

2-Hydroxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 97%, 10g

2-BENZYL-5-BROMOISOINDOLINE-1,3-DIONE, 95.0%, 1g

1-tert-Butoxycarbonylpiperidin-4-one, 98.0%, 500g